Guava Technologies, Inc.
Records under this name other than patents Guava Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Guava Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,184,271 | Differentiation of Flow Cytometry Pulses and Applications merged into Millipore Corporation - now held by Cytek Biosciences, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,885,153 | Differentiation of Flow Cytometry Pulses and Applications merged into Millipore Corporation - now held by Cytek Biosciences, Inc. In force · High confidence | In force | High confidence | |
| US 7,847,923 | Differentiation of Flow Cytometry Pulses and Applications now held by Cytek Biosciences, Inc. In force · High confidence | In force | High confidence | |
| US 10,140,419 | Graphical User Interface for Analysis and Comparison of Location-Specific Multiparameter Data Sets merged into Millipore Corporation - now held by Cytek Biosciences, Inc. In force · High confidence | In force | High confidence | |
| US 8,959,448 | Graphical User Interface for Analysis and Comparison of Location-Specific Multiparameter Data Sets now held by Cytek Biosciences, Inc. In force · High confidence | In force | High confidence | |
| US 7,320,775 | Exchangeable Flow Cell Assembly with a Suspended Capillary now held by Cytek Biosciences, Inc. Term ended Term ended Jun 27, 2024 · High confidence | Term ended | Term ended Jun 27, 2024 | High confidence |
| US 7,410,809 | Particle or Cell Analyzer and Method now held by Cytek Biosciences, Inc. Term ended Term ended Aug 4, 2023 · High confidence | Term ended | Term ended Aug 4, 2023 | High confidence |
| US 7,972,559 | Particle or Cell Analyzer and Method now held by Cytek Biosciences, Inc. Term ended Term ended Feb 3, 2022 · High confidence | Term ended | Term ended Feb 3, 2022 | High confidence |
| US 8,524,489 | Particle or Cell Analyzer and Method merged into Millipore Corporation - now held by Cytek Biosciences, Inc. Term ended Term ended Aug 11, 2021 · High confidence | Term ended | Term ended Aug 11, 2021 | High confidence |
| US 6,403,378 | Cell Viability Assay Reagent now held by Cytek Biosciences, Inc. Term ended Term ended Apr 26, 2021 · High confidence | Term ended | Term ended Apr 26, 2021 | High confidence |